CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells

ABSTRACT:

SUBMITTER: Morishima C 

PROVIDER: S-EPMC4649400 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature